Aldeyra Therapeutics' (ALDX) CEO Todd Brady on COVID-19 Development Update Conference Call - Transcript

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) COVID-19 Development Update Conference Call May 19, 2020 8:10 AM ET Company Participants Joshua Reed – Chief Financial Officer Todd Brady – President and Chief Executive Officer Adam Brockman – Director-Non-Clinical Development Conference Call Participants Louise Chen – Cantor Justin Kim – Oppenheimer Yigal Nochomovitz – Citigroup Yale Jen – Laidlaw & Company Esther Hong – Janney Matthew Cross – JonesTrading Operator Ladies and gentlemen, thank you for standing by an ...